Forget Oral Wegovy: This Weight Loss Drug Could Be an Even Bigger Winner

AI Briefing

• – Novo Nordisk's Wegovy faces competition from Eli Lilly's tirzepatide, as both drugs aim to treat type 2 diabetes and obesity.